Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Outcomes of LASIK utilising new topography-integrated aberrometer
Colman R. Kraff, MD, shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio for the treatment of patients with hyperopia and myopia.
Colman R. Kraff, MD, of Kraff Eye Institute (Chicago, IL), shares highlights of a study evaluating the safety and efficacy of the use of the iDesign 2.0 Refractive Studio, a new topography-integrated, wavefront-guided LASIK procedure, for the treatment of patients with hyperopia and myopia.
Disclaimer/Notes: Dr. Kraff presented this data on behalf of the International Medical Advisory Board for Optical Express. This study was conducted in the United Kingdom and Ireland.
Related Videos
Related Content
